Andata, Zhea .
HRN: 27-35-29 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/23/2025
CEFUROXIME 750MG (VIAL)
06/23/2025
06/30/2025
IV
250mg
Q8
PCAP; UTI
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Urinary TractPneumoniaBloodstreamProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes